SightfileU.S. market data from official filings

Companies › ZSQR

COEPTIS THERAPEUTICS HLDGS I (ZSQR)

Institutional ownership, SEC filings and insider activity

Sector: Financials · SEC CIK 0001759186 · EDGAR filings · Updated 2026-07-27

COEPTIS THERAPEUTICS HLDGS I (ZSQR) has reported institutional ownership of 0.4%, with 12 institutional managers holding positions valued at $5.36M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
0.4%
Institutional managers
12
Reported 13F value
$5.36M
Insider activity
18 trans.
$0 net flat
Data flags
1 active
from SEC filings

Filings this week (2)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, COEPTIS THERAPEUTICS HLDGS I has 12 institutional holders and institutional ownership of 0.4%.

Insider activity

Insiders reported 18 transactions (0 buys, 0 sells) across 9 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2022-04-08) — source filing. The authoritative details are those stated in the filing itself.

Related companies

21SHARES ETHEREUM ETF (TETH) · 21SHARES XRP ETF (TOXR) · SIEBERT FINL CORP (SIEB) · Fold Holdings Inc. (FLD) · Aurelion Inc. (AURE) · DOMINARI HOLDINGS (DOMH)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.